METHOD FOR IMPROVING BIOAVAILABILITY OF NAD+ DERIVATIVES

The present disclosure provides a method for improving bioavailability of an NAD+ derivative. The method improves the bioavailability of the NAD+derivative by arranging a CD38 inhibitor and the NAD+ derivative in a same preparation, and controlling the CD38 inhibitor to release first rapidly, and th...

Full description

Saved in:
Bibliographic Details
Main Authors HOU, Yaying, CHEN, Jiansheng, BAI, Yuqin, ZHANG, Tong, LYU, Jing
Format Patent
LanguageEnglish
Published 02.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides a method for improving bioavailability of an NAD+ derivative. The method improves the bioavailability of the NAD+derivative by arranging a CD38 inhibitor and the NAD+ derivative in a same preparation, and controlling the CD38 inhibitor to release first rapidly, and then the NAD+ derivative releases after the CD38 inhibitor has taken effect, thereby increasing the level of NAD+ in vivo.
Bibliography:Application Number: US202318467740